MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 99 filers reported holding MUSTANG BIO INC in Q4 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $72,000 | -45.9% | 71,297 | -11.3% | 0.00% | – |
| Q4 2021 | $133,000 | -35.1% | 80,405 | +5.4% | 0.00% | – |
| Q3 2021 | $205,000 | -16.7% | 76,281 | +3.0% | 0.00% | – |
| Q2 2021 | $246,000 | +113.9% | 74,090 | +113.3% | 0.00% | – |
| Q1 2021 | $115,000 | -7.3% | 34,734 | +6.0% | 0.00% | – |
| Q4 2020 | $124,000 | +49.4% | 32,774 | +24.1% | 0.00% | – |
| Q3 2020 | $83,000 | -17.0% | 26,404 | -15.6% | 0.00% | – |
| Q2 2020 | $100,000 | +26.6% | 31,294 | +6.5% | 0.00% | – |
| Q1 2020 | $79,000 | -34.2% | 29,391 | 0.0% | 0.00% | – |
| Q4 2019 | $120,000 | +29.0% | 29,391 | +2.8% | 0.00% | – |
| Q3 2019 | $93,000 | -12.3% | 28,591 | -1.0% | 0.00% | – |
| Q2 2019 | $106,000 | +60.6% | 28,866 | +49.2% | 0.00% | – |
| Q1 2019 | $66,000 | +13.8% | 19,348 | -2.2% | 0.00% | – |
| Q4 2018 | $58,000 | -26.6% | 19,788 | +49.9% | 0.00% | – |
| Q3 2018 | $79,000 | -20.2% | 13,198 | -8.5% | 0.00% | – |
| Q2 2018 | $99,000 | – | 14,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
| GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
| Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
| Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
| EMFO, LLC | 32,000 | $32,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
| Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
| Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
| Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |